Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival

被引:19
|
作者
Mastroianni, Riccardo [1 ,2 ]
Brassetti, Ado [1 ]
Krajewski, Wojciech [3 ]
Zdrojowy, Romuald [3 ]
Al Salhi, Yazan [4 ]
Anceschi, Umberto [1 ]
Bove, Alfredo Maria [1 ]
Carbone, Antonio [4 ]
De Nunzio, Cosimo [5 ]
Fuschi, Andrea [4 ]
Ferriero, Mariaconsiglia [1 ]
Nacchia, Antonio [5 ]
Pastore, Antonio Luigi [4 ]
Tema, Giorgia [5 ]
Tuderti, Gabriele [1 ]
Gallucci, Michele [2 ]
Simone, Giuseppe [1 ]
机构
[1] Regina Elena Inst Canc Res, Dept Urol, Via Elio Chianesi 53, I-00154 Rome, RM, Italy
[2] Sapienza Univ, Dept Urol, Rome, Italy
[3] Wroclaw Med Univ, Dept Urol & Urol Oncol, Wroclaw, Poland
[4] Sapienza Univ ICOT, Dept Medico Surg Sci & Biotechnol, Urol Unit, Latina, Italy
[5] St Andrea Hosp, Dept Urol, Rome, Italy
来源
EUROPEAN UROLOGY FOCUS | 2021年 / 7卷 / 06期
关键词
Non-muscle-invasive bladder cancer; Detrusor muscle; Transurethral resection of the bladder; Recurrence-free survival; Low-risk bladder cancer; Intermediate-risk bladder cancer; Low-grade bladder cancer; TRANSURETHRAL RESECTION; EUROPEAN ORGANIZATION; INDIVIDUAL PATIENTS; PROGNOSTIC-FACTORS; STAGE TA; CANCER; RISK; CLASSIFICATION; PROGRESSION; NEOPLASMS;
D O I
10.1016/j.euf.2020.08.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Obtaining detrusor muscle (DM) in transurethral resection of bladder tumor (TURBt) specimen is considered a surrogate marker of resection quality. However, evidence was principally investigated in high-risk tumors. Therefore, DM sampling for low-grade (LG) urothelial carcinoma (UC) remains poorly investigated and certainly requires further investigation. Objective: To assess whether the absence of DM in TURBt specimen has a negative impact on recurrence-free survival (RFS) in patients with a Ta LG UC. Design, setting, and participants: A multicenter TURBt database was queried for "LG, Ta, UC of the bladder." All patients treated between 1996 and 2018 with tumor grade assessed according to both 1973 World Health Organization and 2004 WHO/International Society of Urological Pathology grading classifications and with a minimum follow-up of 1 yr were included. Patients with a previous history of high-grade UC, upper urinary tract UC, or bladder tumor differentiations other than UC were excluded. Intervention: TURBt. Outcome measurements and statistical analysis: Baseline demographic, clinical, and pathologic data were analyzed. The European Organization for Research and Treatment of Cancer (EORTC) risk group was recorded. Kaplan-Meier analysis was performed to assess the predictive role of clinical and pathologic data for RFS. Univariable and multivariable Cox regression analyses were performed to identify the predictors of recurrence. Results and limitations: Overall, 521 patients were included. At Kaplan-Meier analysis, the low-risk cohort displayed significantly higher RFS than the intermediate-risk cohort (1-yr RFS 87% vs 79%; log-rank p = 0.007). At univariable Cox regression analysis, only gender, multiple tumors, tumor diameter >= 3 cm, and EORTC risk group were significant predictors of recurrence. Absence of DM had no impact on RFS. Multivariable Cox regression analysis confirmed gender and EORTC risk group as independent predictors of recurrence. Conclusions: Absence of DM in TURBt specimen has negligible role in RFS of patients with Ta LG tumors of the bladder. Patient summary: In this study, we assessed the role that detrusor muscle (DM) in transurethral resection of bladder tumor specimen has in recurrence-free survival, in patients with a Ta low-grade urothelial carcinoma of the bladder. Absence of DM has no impact on tumor recurrence; therefore, it does not require additional attention. (C) 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1324 / 1331
页数:8
相关论文
共 50 条
  • [31] The Influence of Inverted Growth Pattern on Recurrence for Patients with Non-Invasive Low Grade Papillary Urothelial Carcinoma of Bladder
    Arslankoz, Sehbal
    Kulac, Ibrahim
    Baydar, Dilek Ertoy
    BALKAN MEDICAL JOURNAL, 2017, 34 (05) : 464 - 468
  • [32] Low Ki-67 labeling index is a clinically useful predictive factor for recurrence-free survival in patients with papillary thyroid carcinoma
    Masui, Takashi
    Yane, Katsunari
    Ota, Ichiro
    Kakudo, Kennichi
    Wakasa, Tomoko
    Koike, Satoru
    Kinugawa, Hirotaka
    Yasumatsu, Ryuji
    Kitahara, Tadashi
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2025,
  • [33] Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer
    Yasui, Masato
    Kawahara, Takashi
    Izumi, Koji
    Yao, Masahiro
    Ishiguro, Yukari
    Ishiguro, Hitoshi
    Uemura, Hiroji
    Miyoshi, Yasuhide
    BMC CANCER, 2019, 19 (1)
  • [34] Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum
    Gershenson, David M.
    Sun, Charlotte C.
    Wong, Kwong-Kwok
    BRITISH JOURNAL OF CANCER, 2015, 113 (09) : 1254 - 1258
  • [35] Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection
    Deng Nan
    Chen Jun-xing
    Chen Ling-wu
    Qiu Shao-peng
    Li Xiao-fei
    Wang Dao-hu
    CHINESE MEDICAL JOURNAL, 2012, 125 (20) : 3681 - 3686
  • [36] Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc Analysis
    Corsi, Nicholas J.
    Messing, Edward M.
    Sood, Akshay
    Keeley, Jacob
    Bronkema, Chandler
    Rakic, Nikola
    Jamil, Marcus
    Dalela, Deepansh
    Arora, Sohrab
    Piontkowski, Austin J.
    Majdalany, Sami E.
    Butaney, Mohit
    Rakic, Ivan
    Li, Pin
    Menon, Mani
    Rogers, Craig G.
    Abdollah, Firas
    CLINICAL GENITOURINARY CANCER, 2022, 20 (06) : E498 - E505
  • [37] Maintenance therapy with bacillus Calmette-Guerin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer
    Hinotsu, Shiro
    Akaza, Hideyuki
    Naito, Seiji
    Ozono, Seiichiro
    Sumiyoshi, Yoshiteru
    Noguchi, Sumio
    Yamaguchi, Akito
    Nagamori, Satoshi
    Terai, Akito
    Nasu, Yasutomo
    Kume, Haruki
    Tomita, Yoshihiko
    Tanaka, Yoshinori
    Samma, Shoji
    Uemura, Hirotsugu
    Koga, Hirofumi
    Tsushima, Tomoyasu
    BJU INTERNATIONAL, 2011, 108 (02) : 187 - 195
  • [38] Extensive rhabdomyosarcomatous differentiation in recurrent low-grade urothelial carcinoma of the bladder after transurethral resection: A case report
    Kamei M.
    Shinohara T.
    Kasahara K.
    Kuno T.
    Naruse K.
    Watanabe H.
    Journal of Medical Case Reports, 9 (1)
  • [39] Phosphorylated H2AX in Noninvasive Low Grade Urothelial Carcinoma of the Bladder: Correlation With Tumor Recurrence
    Cheung, Wang L.
    Albadine, Roula
    Chan, Theresa
    Sharma, R.
    Nettot, George J.
    JOURNAL OF UROLOGY, 2009, 181 (03) : 1387 - 1392
  • [40] Development of a New Recurrence-Free Survival Prediction Nomogram for Patients with Primary Non-Muscle-Invasive Bladder Cancer Based on Preoperative Controlling Nutritional Status Score
    Zhao, Liwei
    Sun, Ji
    Wang, Kai
    Tai, Shengcheng
    Hua, Runmiao
    Yu, Yufu
    Fan, Yi
    Huang, Jiaguo
    Fan, Yi
    Huang, Jiaguo
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6473 - 6487